The Experts below are selected from a list of 27577926 Experts worldwide ranked by ideXlab platform
M Graeber - One of the best experts on this subject based on the ideXlab platform.
-
the eczema area and severity index easi assessment of reliability in atopic dermatitis
Experimental Dermatology, 2001Co-Authors: Jon M Hanifin, M Thurston, M Omoto, R Cherill, Susan J Tofte, M GraeberAbstract:Abstract:Objective– To test the reliability of the eczema area and severity index (EASI) scoring system by assessing inter- and intra-observer consistency. Design: Training of Evaluators, application, and assessment over 2 consecutive days. Setting– An academic center. Patients– Twenty adults and children with atopic dermatitis (AD); cohort 1 (10 patients ≥8 years) and cohort 2 (10 patients <8 years). Interventions– None. Main outcome measure– The EASI was used by 15 dermatologist Evaluators to assess atopic dermatitis in cohort 1 and cohort 2 on 2 consecutive days. Inter- and intraobserver reliability were analyzed. Results– Overall intra-Evaluator reliability of the EASI was in the fair-to-good range. Inter-Evaluator reliability analyses indicated that the Evaluators assessed the patients consistently across both study days. Conclusions– This study demonstrated that the EASI can be learned quickly and utilized reliably in the assessment of severity and extent of AD. There was consistency among the Evaluators between consecutive days of evaluation. These results support the use of the EASI in clinical trials of therapeutic agents for AD.
-
the eczema area and severity index easi assessment of reliability in atopic dermatitis easi Evaluator group
Experimental Dermatology, 2001Co-Authors: Jon M Hanifin, M Thurston, M Omoto, R Cherill, Susan J Tofte, M GraeberAbstract:OBJECTIVE: To test the reliability of the eczema area and severity index (EASI) scoring system by assessing inter- and intra-observer consistency. DESIGN: Training of Evaluators, application, and assessment over 2 consecutive days. SETTING: An academic center. PATIENTS: Twenty adults and children with atopic dermatitis (AD); cohort 1 (10 patients > or = 8 years) and cohort 2 (10 patients < 8 years). INTERVENTIONS: None. MAIN OUTCOME MEASURE: The EASI was used by 15 dermatologist Evaluators to assess atopic dermatitis in cohort 1 and cohort 2 on 2 consecutive days. Inter- and intraobserver reliability were analyzed. RESULTS: Overall intra-Evaluator reliability of the EASI was in the fair-to-good range. Inter-Evaluator reliability analyses indicated that the Evaluators assessed the patients consistently across both study days. CONCLUSIONS: This study demonstrated that the EASI can be learned quickly and utilized reliably in the assessment of severity and extent of AD. There was consistency among the Evaluators between consecutive days of evaluation. These results support the use of the EASI in clinical trials of therapeutic agents for AD.
Antonio Piccinno - One of the best experts on this subject based on the ideXlab platform.
-
a tool to support usability inspection
Advanced Visual Interfaces, 2006Co-Authors: Carmelo Ardito, Rosa Lanzilotti, Paolo Buono, Antonio PiccinnoAbstract:SUIT (Systematic Usability Inspection Tool) is an Internet-based tool that supports the Evaluators during the usability inspection of software applications. SUIT makes it possible to reach inspectors everywhere, guiding them in their activities. Differently from other tools that have been proposed in literature, SUIT not only supports the activities of a single Evaluator, but permits to manage a team of Evaluators who can perform peer reviews of their inspection works and merge their individual reports in a single document on which they agree.
-
AVI - A tool to support usability inspection
Proceedings of the working conference on Advanced visual interfaces - AVI '06, 2006Co-Authors: Carmelo Ardito, Rosa Lanzilotti, Paolo Buono, Antonio PiccinnoAbstract:SUIT (Systematic Usability Inspection Tool) is an Internet-based tool that supports the Evaluators during the usability inspection of software applications. SUIT makes it possible to reach inspectors everywhere, guiding them in their activities. Differently from other tools that have been proposed in literature, SUIT not only supports the activities of a single Evaluator, but permits to manage a team of Evaluators who can perform peer reviews of their inspection works and merge their individual reports in a single document on which they agree
Michele J Gelfand - One of the best experts on this subject based on the ideXlab platform.
-
status and the evaluation of workplace deviance
Psychological Science, 2010Co-Authors: Hannah Riley Bowles, Michele J GelfandAbstract:Bias in the evaluation of workplace misbehavior is hotly debated in courts and corporations, but it has received little empirical attention. Classic sociological literature suggests that deviance by lower-status actors will be evaluated more harshly than deviance by higher-status actors. However, more recent psychological literature suggests that discrimination in the evaluation of misbehavior may be moderated by the relative status of the Evaluator because status influences both rule observance and attitudes toward social hierarchy. In Study 1, the psychological experience of higher status decreased rule observance and increased preferences for social hierarchy, as we theorized. In three subsequent experiments, we tested the hypothesis that higher-status Evaluators would be more discriminating in their evaluations of workplace misbehavior, evaluating fellow higher-status deviants more leniently than lower-status deviants. Results supported the hypothesized interactive effect of Evaluator status and targe...
-
Status and the Evaluation of Workplace Deviance
Psychological science, 2009Co-Authors: Hannah Riley Bowles, Michele J GelfandAbstract:Bias in the evaluation of workplace misbehavior is hotly debated in courts and corporations, but it has received little empirical attention. Classic sociological literature suggests that deviance by lower-status actors will be evaluated more harshly than deviance by higher-status actors. However, more recent psychological literature suggests that discrimination in the evaluation of misbehavior may be moderated by the relative status of the Evaluator because status influences both rule observance and attitudes toward social hierarchy. In Study 1, the psychological experience of higher status decreased rule observance and increased preferences for social hierarchy, as we theorized. In three subsequent experiments, we tested the hypothesis that higher-status Evaluators would be more discriminating in their evaluations of workplace misbehavior, evaluating fellow higher-status deviants more leniently than lower-status deviants. Results supported the hypothesized interactive effect of Evaluator status and target status on the evaluation of workplace deviance, when both achieved status characteristics (Studies 2a and 2b) and ascribed status characteristics (i.e., race and gender in Study 3) were manipulated.
M Thurston - One of the best experts on this subject based on the ideXlab platform.
-
the eczema area and severity index easi assessment of reliability in atopic dermatitis
Experimental Dermatology, 2001Co-Authors: Jon M Hanifin, M Thurston, M Omoto, R Cherill, Susan J Tofte, M GraeberAbstract:Abstract:Objective– To test the reliability of the eczema area and severity index (EASI) scoring system by assessing inter- and intra-observer consistency. Design: Training of Evaluators, application, and assessment over 2 consecutive days. Setting– An academic center. Patients– Twenty adults and children with atopic dermatitis (AD); cohort 1 (10 patients ≥8 years) and cohort 2 (10 patients <8 years). Interventions– None. Main outcome measure– The EASI was used by 15 dermatologist Evaluators to assess atopic dermatitis in cohort 1 and cohort 2 on 2 consecutive days. Inter- and intraobserver reliability were analyzed. Results– Overall intra-Evaluator reliability of the EASI was in the fair-to-good range. Inter-Evaluator reliability analyses indicated that the Evaluators assessed the patients consistently across both study days. Conclusions– This study demonstrated that the EASI can be learned quickly and utilized reliably in the assessment of severity and extent of AD. There was consistency among the Evaluators between consecutive days of evaluation. These results support the use of the EASI in clinical trials of therapeutic agents for AD.
-
the eczema area and severity index easi assessment of reliability in atopic dermatitis easi Evaluator group
Experimental Dermatology, 2001Co-Authors: Jon M Hanifin, M Thurston, M Omoto, R Cherill, Susan J Tofte, M GraeberAbstract:OBJECTIVE: To test the reliability of the eczema area and severity index (EASI) scoring system by assessing inter- and intra-observer consistency. DESIGN: Training of Evaluators, application, and assessment over 2 consecutive days. SETTING: An academic center. PATIENTS: Twenty adults and children with atopic dermatitis (AD); cohort 1 (10 patients > or = 8 years) and cohort 2 (10 patients < 8 years). INTERVENTIONS: None. MAIN OUTCOME MEASURE: The EASI was used by 15 dermatologist Evaluators to assess atopic dermatitis in cohort 1 and cohort 2 on 2 consecutive days. Inter- and intraobserver reliability were analyzed. RESULTS: Overall intra-Evaluator reliability of the EASI was in the fair-to-good range. Inter-Evaluator reliability analyses indicated that the Evaluators assessed the patients consistently across both study days. CONCLUSIONS: This study demonstrated that the EASI can be learned quickly and utilized reliably in the assessment of severity and extent of AD. There was consistency among the Evaluators between consecutive days of evaluation. These results support the use of the EASI in clinical trials of therapeutic agents for AD.
M Omoto - One of the best experts on this subject based on the ideXlab platform.
-
the eczema area and severity index easi assessment of reliability in atopic dermatitis
Experimental Dermatology, 2001Co-Authors: Jon M Hanifin, M Thurston, M Omoto, R Cherill, Susan J Tofte, M GraeberAbstract:Abstract:Objective– To test the reliability of the eczema area and severity index (EASI) scoring system by assessing inter- and intra-observer consistency. Design: Training of Evaluators, application, and assessment over 2 consecutive days. Setting– An academic center. Patients– Twenty adults and children with atopic dermatitis (AD); cohort 1 (10 patients ≥8 years) and cohort 2 (10 patients <8 years). Interventions– None. Main outcome measure– The EASI was used by 15 dermatologist Evaluators to assess atopic dermatitis in cohort 1 and cohort 2 on 2 consecutive days. Inter- and intraobserver reliability were analyzed. Results– Overall intra-Evaluator reliability of the EASI was in the fair-to-good range. Inter-Evaluator reliability analyses indicated that the Evaluators assessed the patients consistently across both study days. Conclusions– This study demonstrated that the EASI can be learned quickly and utilized reliably in the assessment of severity and extent of AD. There was consistency among the Evaluators between consecutive days of evaluation. These results support the use of the EASI in clinical trials of therapeutic agents for AD.
-
the eczema area and severity index easi assessment of reliability in atopic dermatitis easi Evaluator group
Experimental Dermatology, 2001Co-Authors: Jon M Hanifin, M Thurston, M Omoto, R Cherill, Susan J Tofte, M GraeberAbstract:OBJECTIVE: To test the reliability of the eczema area and severity index (EASI) scoring system by assessing inter- and intra-observer consistency. DESIGN: Training of Evaluators, application, and assessment over 2 consecutive days. SETTING: An academic center. PATIENTS: Twenty adults and children with atopic dermatitis (AD); cohort 1 (10 patients > or = 8 years) and cohort 2 (10 patients < 8 years). INTERVENTIONS: None. MAIN OUTCOME MEASURE: The EASI was used by 15 dermatologist Evaluators to assess atopic dermatitis in cohort 1 and cohort 2 on 2 consecutive days. Inter- and intraobserver reliability were analyzed. RESULTS: Overall intra-Evaluator reliability of the EASI was in the fair-to-good range. Inter-Evaluator reliability analyses indicated that the Evaluators assessed the patients consistently across both study days. CONCLUSIONS: This study demonstrated that the EASI can be learned quickly and utilized reliably in the assessment of severity and extent of AD. There was consistency among the Evaluators between consecutive days of evaluation. These results support the use of the EASI in clinical trials of therapeutic agents for AD.
